We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00920712
First Posted: June 15, 2009
Last Update Posted: April 19, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Shanghai University of Traditional Chinese Medicine
June 11, 2009
June 15, 2009
April 19, 2016
August 2009
June 2012   (Final data collection date for primary outcome measure)
Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change [ Time Frame: 12 weeks ]
Same as current
Complete list of historical versions of study NCT00920712 on ClinicalTrials.gov Archive Site
Indicates of liver and renal function [ Time Frame: 12 weeks ]
Same as current
Not Provided
Not Provided
 
Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis
Not Provided
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Gastritis
Drug: Weiqi decotion
Decoction ,two times a day
  • Experimental: Weiqi decoction
    Intervention: Drug: Weiqi decotion
  • Placebo Comparator: low dose of Weiqi decoction
    Intervention: Drug: Weiqi decotion
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
July 2012
June 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of Chronic Atrophic Gastritis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion Criteria:

  • Combine with malignant pathology on epithelial dysplasia of gastric mucosa
  • Combine with duodenal ulcer or gastric ulcer
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
China
 
 
NCT00920712
SHTCM-001
Yes
Not Provided
Not Provided
Shanghai University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Not Provided
Study Director: Xie Jianqun, Phd Shanghai University of Chinese Medicine
Shanghai University of Traditional Chinese Medicine
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP